Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Strides Singapore arm bags USFDA nod for Mycophenolate Mofetil for Oral Suspension

Ruchika Sharma31 Aug 2023 1:30 PM IST

Mycophenolate Mofetil for Oral Suspension belongs to a group of medicines called immunosuppressants.

Lupin secures SBTi validation for emission reduction targets

Lupin arm unveils heart drug in Canada

Ruchika Sharma31 Aug 2023 12:36 PM IST

Montreal: Lupin Pharma Canada Ltd., a wholly-owned subsidiary of Lupin Limited has announced the launch of Propranolol LA (long-acting) capsules, 60...

Ajanta Pharma Sets Up Wholly Owned Subsidiary in Ireland

Ajanta Pharma bags USFDA nod for migraine drug Topiramate ER

Ruchika Sharma31 Aug 2023 11:54 AM IST

Mumbai: Ajanta Pharma Limited, a speciality pharmaceutical formulation company, has received final approval from the United States Food and Drug...

Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE Mark

Roche Evrysdi gets European Commission nod for babies under two months old with spinal muscular atrophy

Ruchika Sharma30 Aug 2023 3:00 PM IST

Basel: Roche has announced that the European Commission has approved the extension of the Evrysdi (risdiplam) European Union (EU) marketing...

Shukra Pharma Signs MoU With US Firm for AI Surgical Robotics in India

ImmunoGen, Takeda ink pact to develop, commercialize Elahere in Japan

Ruchika Sharma30 Aug 2023 1:00 PM IST

Per the agreement, ImmunoGen has retained exclusive production rights and will supply product for development and commercial use in Japan.

Eli Lilly joins trillion-dollar club, fueled by weight loss drug demand boom

Europe to face shortage of Eli Lilly diabetes drug Trulicity through September

Ruchika Sharma30 Aug 2023 11:30 AM IST

Europe: Europe will continue to face a shortage of Eli Lilly & Co's blockbuster diabetes drug Trulicity through September, the European Medicines...

Pfizer expects to restart production at tornado hit plant by early Q4

Ruchika Sharma30 Aug 2023 10:00 AM IST

North Carolina: Pfizer said on Monday it expects to restart production at its North Carolina plant by the beginning of the fourth quarter of...

AstraZeneca Soliris approved in Japan for paediatric patients with generalised myasthenia gravis

Ruchika Sharma29 Aug 2023 4:14 PM IST

Cambridge: AstraZeneca's Soliris (eculizumab) has been approved in Japan for expanded use to include the treatment of generalised myasthenia gravis...

Venus Remedies gets Saudi marketing approval for Enoxaparin in pre-filled syringes

Ruchika Sharma29 Aug 2023 3:00 PM IST

Enoxaparin plays a crucial role in addressing the grave concern of blood clot formation in patients suffering from deep-vein thrombosis, acute...

Sun Pharma, Philogen complete patient enrollment in Phase III trial for Soft Tissue Sarcoma

Sun Pharma aims to spend 7-8 percent of sales in current fiscal on RnD

Ruchika Sharma29 Aug 2023 1:00 PM IST

According to Shanghvi, the domestic pharmaceutical market size is estimated to reach USD 35-39 billion by 2027, recording 7.5-10.5 per cent compounded...

Janssen seeks expanded USFDA approval for Rybrevant in combination with chemotherapy

Ruchika Sharma29 Aug 2023 12:00 PM IST

Raritan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a supplemental Biologics License ...

Bristol Myers Squibb Breyanzi approved by USFDA for adults with Marginal Zone Lymphoma

Bristol Myers Squibb gets USFDA nod for Reblozyl as first line treatment of Anemia in lower risk MDS

Ruchika Sharma29 Aug 2023 11:09 AM IST

Reblozyl, a first-in-class therapeutic option, promotes late-stage red blood cell maturation in animal models.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok